Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Acta Neurol Belg ; 121(3): 625-631, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33515404

ABSTRACT

Harlequin syndrome is a rare condition, presenting with unilateral facial flushing and hyperhidrosis in response to physical exercise, heat or emotional stressors and has scarcely been reported in pediatric patients. It is caused by a dysfunction of vasomotor and sudomotor sympathetic fiber activity inhibiting the ability to flush on the affected side, causing the neurologically intact side to appear red. We present three pediatric cases of this uncommon syndrome, each of them of different origin and displaying distinct associated (neurological) symptoms, and review medical literature. Insight into the anatomical structure of the thoracocervical and facial sympathetic nervous system is pivotal as it dictates symptomatology. About half of Harlequin syndrome cases are complicated with ocular symptoms and a minority may be part of more extensive partial dysautonomias affecting facial sudomotor, vasomotor and pupillary responses, such as Holmes-Adie syndrome and Ross syndrome. Etiology is generally idiopathic, however, cases secondary to surgery, trauma or infection have been described. Considering its predominantly self-limiting nature, treatment is usually unnecessary and should be restricted to incapacitating cases.


Subject(s)
Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System/physiopathology , Flushing/diagnosis , Hypohidrosis/diagnosis , Autonomic Nervous System Diseases/physiopathology , Child, Preschool , Female , Flushing/physiopathology , Humans , Hypohidrosis/physiopathology
2.
Dev Med Child Neurol ; 52(6): 570-5, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20132143

ABSTRACT

AIM: This study investigated the reliability and validity of the Barry-Albright Dystonia Scale (BADS), the Burke-Fahn-Marsden Movement Scale (BFMMS), and the Unified Dystonia Rating Scale (UDRS) in patients with bilateral dystonic cerebral palsy (CP). METHOD: Three raters independently scored videotapes of 10 patients (five males, five females; mean age 13 y 3 mo, SD 5 y 2 mo, range 5-22 y). One patient each was classified at levels I-IV in the Gross Motor Function Classification System and six patients were classified at level V. Reliability was measured by (1) intraclass correlation coefficient (ICC) for interrater reliability, (2) standard error of measurement (SEM) and smallest detectable difference (SDD), and (3) Cronbach's alpha for internal consistency. Validity was assessed by Pearson's correlations among the three scales used and by content analysis. RESULTS: Moderate to good interrater reliability was found for total scores of the three scales (ICC: BADS=0.87; BFMMS=0.86; UDRS=0.79). However, many subitems showed low reliability, in particular for the UDRS. SEM and SDD were respectively 6.36% and 17.72% for the BADS, 9.88% and 27.39% for the BFMMS, and 8.89% and 24.63% for the UDRS. High internal consistency was found. Pearson's correlations were high. Content validity showed insufficient accordance with the new CP definition and classification. INTERPRETATION: Our results support the internal consistency and concurrent validity of the scales; however, taking into consideration the limitations in reliability, including the large SDD values and the content validity, further research on methods of assessment of dystonia is warranted.


Subject(s)
Cerebral Palsy/complications , Cerebral Palsy/diagnosis , Dystonia/complications , Dystonia/diagnosis , Adolescent , Child , Child, Preschool , Disability Evaluation , Female , Humans , Male , Observer Variation , Severity of Illness Index , Young Adult
3.
Neurology ; 73(14): 1111-9, 2009 Oct 06.
Article in English | MEDLINE | ID: mdl-19805727

ABSTRACT

OBJECTIVE: Hereditary spastic paraplegias (HSPs) are very heterogeneous inherited neurodegenerative disorders. Our group recently identified ZFYVE26 as the gene responsible for one of the clinical and genetic entities, SPG15. Our aim was to describe its clinical and mutational spectra. METHODS: We analyzed all exons of SPG15/ZFYVE26 gene by direct sequencing in a series of 60 non-SPG11 HSP subjects with associated mental or MRI abnormalities, including 30 isolated cases. The clinical data were collected through the SPATAX network. RESULTS: We identified 13 novel truncating mutations in ZFYVE26, 12 of which segregated at the homozygous or compound heterozygous states in 8 new SPG15 families while 1 was found at the heterozygous state in a single family. Two of 3 splice site mutations were validated on mRNA of 2 patients. The SPG15 phenotype in 11 affected individuals was characterized by early onset HSP, severe progression of the disease, and mental impairment dominated by cognitive decline. Thin corpus callosum and white matter hyperintensities were MRI hallmarks of the disease in this series. CONCLUSIONS: The mutations are truncating, private, and distributed along the entire coding sequence of ZFYVE26, which complicates the analysis of this gene in clinical practice. In our series of patients with hereditary spastic paraplegia-thin corpus callosum, the largest analyzed so far, SPG15 was the second most frequent form (11.5%) after SPG11. Both forms share similar clinical and imaging presentations with very few distinctions, which are, however, insufficient to infer the molecular diagnosis when faced with a single patient.


Subject(s)
Carrier Proteins/genetics , Corpus Callosum/pathology , Mutation , Spastic Paraplegia, Hereditary/genetics , Spastic Paraplegia, Hereditary/pathology , Adolescent , Brain/diagnostic imaging , Brain/pathology , Child , Corpus Callosum/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Male , Positron-Emission Tomography/methods , Severity of Illness Index , Spastic Paraplegia, Hereditary/diagnostic imaging , Tomography, Emission-Computed, Single-Photon/methods
4.
Neuropediatrics ; 38(4): 179-83, 2007 Aug.
Article in English | MEDLINE | ID: mdl-18058624

ABSTRACT

Rett syndrome was associated with low cerebrospinal fluid (CSF) 5-methyltetrahydrofolate (5MTHF) in 42-50% of European patients whereas approximately 93% of the patients from North-America had a normal CSF 5MTHF status. We determined the CSF folate status in Rett patients living in North- and South-Western Europe and measured serum folate receptor (FR) autoantibodies of the blocking type to explain the reduced folate transport across the choroid plexus. Irrespective of their MECP2 genotype and despite normal plasma folate values, 14 of 33 Rett patients (42%) had low CSF folate levels. Blocking FR autoantibodies were found in 8 of the Rett patients (24%), 6 of whom had low CSF folate levels. FR autoimmunity was primarily found within the group of Rett patients with low CSF folate status with a higher incidence in North-Western Europe. In Rett patients from North-America 74 of 76 girls had higher folate values in both serum and CSF than European patients. The food folate fortification in North-America may account for the higher folate levels and may prevent CFD in these Rett patients. FR autoimmunity occurred predominantly in Rett patients from North-Western Europe and may contribute to cerebral folate deficiency (CFD).


Subject(s)
Autoantibodies/metabolism , Carrier Proteins/immunology , Receptors, Cell Surface/immunology , Rett Syndrome/cerebrospinal fluid , Rett Syndrome/immunology , Tetrahydrofolates/deficiency , Adolescent , Adult , Child , Child, Preschool , Europe/epidemiology , Female , Folate Receptors, GPI-Anchored , Humans , Male , Rett Syndrome/epidemiology , Rett Syndrome/genetics
5.
Phytomedicine ; 13(9-10): 732-4, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16678392

ABSTRACT

Chalcones xanthohumol (X) and desmethylxanthohumol (DMX), present in hops (Humulus lupulus L.), and the corresponding flavanones isoxanthohumol (IX, from X), 8-prenylnaringenin (8-PN, from DMX), and 6-prenylnaringenin (6-PN, from DMX), have been examined in vitro for their anti-proliferative activity on human prostate cancer cells PC-3 and DU145. X proved to be the most active compound in inhibiting the growth of the cell lines with IC50 values of 12.3+/-1.1 microM for DU145 and 13.2+/-1.1 microM for PC-3. 6-PN was the second most active growth inhibitor, particularly in PC-3 cells (IC50 of 18.4+/-1.2 microM). 8-PN, a highly potent phytoestrogen, exhibited pronounced anti-proliferative effects on PC-3 and DU145 (IC50 of 33.5+/-1.0 and 43.1+/-1.2 microM, respectively), and IX gave comparable activities (IC50 of 45.2+/-1.1 microM for PC-3 and 47.4+/-1.1 microM for DU145). DMX was the least active compound. It was evidenced for the first time that this family of prenylated flavonoids from hops effectively inhibits proliferation of prostate cancer cells in vitro.


Subject(s)
Cell Proliferation/drug effects , Flavonoids/pharmacology , Humulus/chemistry , Phytotherapy , Propiophenones/pharmacology , Prostatic Neoplasms/drug therapy , Cell Line, Tumor , Flavonoids/isolation & purification , Humans , Male , Propiophenones/isolation & purification , Prostatic Neoplasms/pathology
6.
Arch Dis Child Fetal Neonatal Ed ; 82(1): F59-63, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10634844

ABSTRACT

AIM: To define neonatal pial middle cerebral artery infarction. METHODS: A retrospective study was made of neonates in whom focal arterial infarction had been detected ultrasonographically. A detailed study was made of cortical middle cerebral artery infarction subtypes. RESULTS: Forty infarctions, with the exception of those in a posterior cerebral artery, were detected ultrasonographically over a period of 10 years. Most were confirmed by computed tomography or magnetic resonance imaging. Factor V Leiden heterozygosity was documented in three. The onset was probably antepartum in three, and associated with fetal distress before labour in one. There were 19 cases of cortical middle cerebral artery stroke. The truncal type (n=13) was more common than complete (n = 5) middle cerebral artery infarction. Of six infarcts in the anterior trunk, four were in term infants and five affected the right hemisphere. Clinical seizures were part of the anterior truncal presentation in three. One of these infants, with involvement of the primary motor area, developed a severe motor hemisyndrome. The Bayley Mental Developmental Index was above 80 in all of three infants tested with anterior truncal infarction. Of seven patients with posterior truncal infarction, six were at or near term. Six of these lesions were left sided. Clinical seizures were observed in three. A mild motor hemisyndrome developed in at least three of these infants due to involvement of parieto-temporal non-primary cortex. CONCLUSIONS: Inability to differentiate between truncal and complete middle cerebral artery stroke is one of the explanations for the reported different outcomes. Severe motor hemisyndrome can be predicted from neonatal ultrasonography on the basis of primary motor cortex involvement. Clinical seizures were recognised in less than half of the patients with truncal infarction; left sided presentation was present in the posterior, but not the anterior truncal type of infarction. Asphyxia is a rare cause of focal arterial infarction.


Subject(s)
Infarction, Middle Cerebral Artery/classification , Asphyxia Neonatorum/complications , Child Development , Factor V/genetics , Female , Fetal Distress/complications , Follow-Up Studies , Heterozygote , Humans , Infant, Newborn , Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/etiology , Infarction, Middle Cerebral Artery/genetics , Magnetic Resonance Imaging , Male , Motor Cortex/physiopathology , Movement Disorders/etiology , Outcome Assessment, Health Care , Parietal Lobe/physiopathology , Pia Mater/blood supply , Point Mutation/genetics , Retrospective Studies , Seizures/physiopathology , Stroke/classification , Temporal Lobe/physiopathology , Tomography, X-Ray Computed , Ultrasonography
7.
Eur J Paediatr Neurol ; 3(2): 59-63, 1999.
Article in English | MEDLINE | ID: mdl-10700540

ABSTRACT

Only incidental mention has been made to date of the combined occurrence of subependymal heterotopia and posterior encephalocele. We evaluated the presence of disseminated nodular subependymal heterotopia in two series of patients with posterior encephalocele. The first series consisted of all six patients who were treated in our hospital for encephalocele during the last 11 years and who underwent magnetic resonance imaging (MRI). In three, subependymal nodular heterotopia was found by MRI. The second series consisted of eight autopsy cases with encephalocele, representing all cases of encephalocele that came to autopsy during a 10-year period on whom full microscopic examination could be performed. Nodular heterotopia was found in four. The combined occurrence of these two rare conditions may not be accidental.


Subject(s)
Brain Diseases/diagnosis , Choristoma/diagnosis , Encephalocele/diagnosis , Ependyma , Magnetic Resonance Imaging , Meningocele/diagnosis , Brain Diseases/pathology , Cerebral Cortex/pathology , Cerebral Ventricles/pathology , Choristoma/pathology , Encephalocele/pathology , Ependyma/pathology , Female , Humans , Infant , Infant, Newborn , Male , Meningocele/pathology , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...